Researchers create unique bioengineered organoids for modeling colorectal cancerDecember 05, 2017
New Rochelle, NY, December 5,2017--A new study describes a unique bioengineered tissue construct, or organoid, into which colorectal cancer cells are embedded, creating a model of the tumor and surrounding extracellular matrix (ECM). Researchers can use this model to study how the physical features of the ECM affect the behavior, growth, and even susceptibility to chemotherapy, as described in an article published in Tissue Engineering, Part A, peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Tissue Engineeringwebsite until January 5, 2018.
This article is the winner of the 2017 Mary Ann Liebert, Inc. Outstanding Student Award, which will be presented at the TERMIS Americas meeting on December 6th to coauthor Mahesh Devarasetty, PhD, Wake Forest School of Medicine.
In the article entitled "Bioengineered Submucosal Organoids for in vitro Modeling of Colorectal Cancer," coauthors Devarasetty, Shay Soker, PhD and colleagues from Wake Forest School of Medicine and Wake Forest Baptist Medical Center, Winston-Salem, NC, report on the method they developed to produce the submucosal organoids using primary smooth muscle cells embedded in collagen hydrogel. This approach yielded a tumor ECM with aligned and parallel fibers, creating a topography around the tumor similar to what is seen in tumors in the body. The authors propose that in the future these organoids could be made using a patient's own cells for personalized medicine applications.
"Our increasing understanding of tumor architecture is guiding the development of tumor extracellular matrix 'mimics' that better reflect the tumor microenvironment and thereby create more realistic systems for assessing tumor cell behavior in response to treatment," says Tissue Engineering Co-Editor-in-Chief Peter C. Johnson, MD, Principal, MedSurgPI, LLC and President and CEO, Scintellix, LLC, Raleigh, NC.
About the Journal
Tissue Engineering is an authoritative peer-reviewed journal published monthly online and in print in three parts: Part A, the flagship journal published 24 times per year; Part B: Reviews, published bimonthly, and Part C: Methods, published 12 times per year. Led by Co-Editors-In-Chief Antonios G. Mikos, PhD, Louis Calder Professor at Rice University, Houston, TX, and Peter C. Johnson, MD, Principal, MedSurgPI, LLC and President and CEO, Scintellix, LLC, Raleigh, NC, the Journal brings together scientific and medical experts in the fields of biomedical engineering, material science, molecular and cellular biology, and genetic engineering. Leadership of Tissue Engineering Parts B (Reviews) and Part C (Methods) is provided by John P. Fisher, PhD, University of Maryland and John A. Jansen, DDS, PhD, Radboud University, respectively. Complete tables of content and a sample issue may be viewed online at the Tissue Engineering website. Tissue Engineering is the official journal of the Tissue Engineering & Regenerative Medicine International Society (TERMIS). Complete tables of content and a sample issue may be viewed on the Tissue Engineering website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Stem Cells and Development, Human Gene Therapy, and Advances in Wound Care. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
Mary Ann Liebert, Inc./Genetic Engineering News
Related Colorectal Cancer Articles:
A highly sensitive method that can detect even the earlier stages of colorectal cancer has been developed by researchers in Japan.
Colorectal cancer is the fourth most common type of cancer in the United States, with nearly 135,000 cases reported in 2016.
Despite dramatic reductions in overall colorectal cancer incidence and mortality, striking disparities by age, race, and tumor subsite remain
While many patients with colorectal are diagnosed when they are older than 50, about 10 percent of patients are diagnosed at younger ages.
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
Sanford Health has opened another clinical trial exploring the power of the body's immune system to fight cancer.
Selenium has been a popular nutritional supplement for decades, touted for its antioxidant properties and its role in stopping free radicals from damaging cells and DNA.
Bacteria commonly found in the mouth have been recently shown to worsen colorectal cancer in animals, but it has not been clear how these microbes make their way to the gut in the first place.
An emerging cancer therapy has colorectal tumors surrounded. Presenters at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging are unveiling a novel radioimmunotherapy that combines a cancer-seeking antibody with potent radionuclide agents, resulting in complete remission of colorectal cancer in mouse models.
University of Colorado Cancer Center study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2016 finds that in patients over 50, the rate of CRC is falling at 2.5 percent per year while the rate of CRC in patients under 50 is rising at 0.8 percent per year.
Related Colorectal Cancer Reading:
Be a Survivor - Colorectal Cancer Treatment Guide
by Vladimir Lange (Author)
This much-needed colorectal cancer resource is developed in consultation with a large national team of experts and endorsed not only by the American Society of Colon and Rectal Surgeons but also by the National non-profit the Colon Cancer Alliance. As with all of the Be a Survivor resources this book features candid testimonials by survivors. It is straightforward, easy-to-understand and contains objective and up-to-date information. The beautiful color photos and graphics enhance the learning process. Most importantly the book leaves the reader with a message of hope. The book addresses each... View Details
Positive Options for Colorectal Cancer: Self-Help and Treatment
by Carol Ann Larson (Author), Kathleen Ogle M.D. (Foreword)
Did you know:
* Approximately 80-90 million Americans are considered at risk for developing colorectal cancer
* More than 147,000 new cases of colorectal cancer will be diagnosed this year in the US.
* Colorectal cancer is the second leading cancer killer of adults in America, and the 4th most commonly diagnosed cancer
* Although the majority of people diagnosed with colorectal cancer are over 50, it can strike people of any age, any race
Written by one of the founding members of Advocates for Colorectal Education, (ACE), this book contains everything you need to know about... View Details
Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)
by Leonard B. Saltz (Editor)
Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and others are in the late phases of clinical development. Likewise, surgical and ablative options, as well as an array of supportive medications, have shown substantial progress and undergone a dramatic proliferation over the past decade. With the increased number of therapeutic options from which to... View Details
Positive Options for Colorectal Cancer, Second Edition: Self-Help and Treatment (Positive Options for Health)
by Carol Ann Larson (Author), Kathleen Ogle M.D. (Foreword)
Positive Options for Colorectal Cancer offers readers everything they need to know about understanding and dealing with colorectal cancer. It presents detailed information in a clear and concise manner from a well-known advocate and author who is a personal survivor of Stage III colorectal cancer for more than 20 years. Chapters present information on prevention techniques, warning signs, and screening tests including the latest on virtual colonoscopy and how to find and talk honestly with the right doctor. It offers tips on treatment options including surgery, chemotherapy, radiation... View Details
American Cancer Society's Complete Guide to Colorectal Caner
by American Cancer Society (Author)
Don't die of embarrassment--get informed about colorectal cancer
Although colorectal cancer is the third most common cancer found in men and women, you may be unaware of your risk and don't know what you can do to prevent this serious disease. You may be too embarrassed to ask your doctor about changes in your bowel habits or get screened for colorectal cancer. American Cancer Society's Complete Guide to Colorectal Cancer provides sound information and support if you are concerned about or diagnosed with colorectal cancer.
Written by experts in oncology,... View Details
Colorectal Cancer: A True Story
by K. Raveendran
This is the real story of a rectal cancer patient. It covers the the mental, physical and emotional condition of the patient during diagnosis, treatment and beyond. It gives you detailed information about what you need to learn about the disease viz.screening tests, special tests, treatment - chemotherapy, radiation therapy and its side effects, diet plan, what precautions to be taken to ensure that the doctors treating the patient gives right advice, what they don't tell you and in such a case what needs to be done.
It also gives indepth insight into the patients mental and... View Details
Understanding Colorectal Cancer Anatomical Chart
by Anatomical Chart Company (Author)
Understanding Colorectal Cancer Anatomical Chart defines colorectal cancer and shows colorectal anatomy with the following pathologies: Adenocarcinoma of colon Circumferential carcinoma of the transverse colon Colonic polyps Adenocarcinoma of jejunum Adenocarcinoma of the rectosigmoid region
The chart describes risk factors, signs and symptoms, screening and diagnostic tests, and treatment options, and illustrates and explains the stages of cancer.View Details
The Colon Cancer Diet
by Dr. Christopher J. Maloney N.D. (Author)
Do you have colon cancer? Does someone you love? Did you know that eating differently, even after you are diagnosed, can lower your risk of dying? When you finish this book I want you to be able to tell me, in a minute or less, how you should eat, exercise, and supplement to lower your risk of dying as a diagnosed colon cancer patient. Last year when I when I was diagnosed I went looking for this book. With all the diet books, I figured someone had written a book specifically for newly diagnosed colon cancer patients. But there was nothing. I checked with my doctors and with the... View Details
Colorectal Cancer: Methods and Protocols (Methods in Molecular Biology)
by Jean-François Beaulieu (Editor)
This volume explores the latest developments in the study of the mechanisms, diagnostics, screening methods, and therapeutics of colorectal cancer. The book’s chapters are divided into three parts: the chapters in Part One examine techniques used to study the molecular mechanisms in colorectal cancer development and progression. Part Two focuses on the innovative tools used to diagnose and detect cancer lesions in the early stages of cancer. Finally, Part Three discusses recent advancements in treating colorectal tumors and identifying new therapeutic molecules for treatment. Written in... View Details
Colorectal Cancer (Oxford Oncology Library)
by Daniel Swinson (Author), Matthew Seymour (Author)
Colorectal cancer is one of the leading causes of cancer-related death in the world. Twenty-five percent of patients present with advanced disease and, despite complete surgical resection of early stage disease, 50% of patients relapse. The treatment of colorectal cancer has advanced rapidly in recent years, and controversies persist regarding optimal management (e.g. whether combination chemotherapy should be used first-line or in a staged fashion, how long to treat patients for and whether to use an intermittent or continuous schedule and whether to refer for a radical approach for advanced... View Details